What Malaria Teaches Us About Lyme Disease Persisters

Can Lyme disease bacteria persist after treatment?
Malaria provides an established example of microbial dormancy and relapse.
Lyme persister research may offer clues—but important questions remain.

Researchers studying malaria have long examined how parasites evade treatment and survive within the body. Lyme disease researchers have explored whether some of these concepts could help explain Borrelia burgdorferi persistence, drug-tolerant persister cells, and ongoing symptoms after treatment.

The comparison raises an important question: can certain microbes survive treatment by entering biologic states that make eradication more difficult?

Malaria provides an established example of microbial dormancy and relapse. In Lyme disease, however, the clinical significance of persister cells remains uncertain.

Why Malaria Research Matters

In Plasmodium vivax and Plasmodium ovale malaria, dormant liver-stage parasites called hypnozoites can reactivate and cause relapses months or even years later. This is an established mechanism of malaria recurrence.

These findings have encouraged researchers studying other infections to examine how pathogens may enter dormant or slow-growing states, evade immune responses, and survive medications.

Although malaria and Lyme disease are very different infections—malaria is caused by a parasite and Lyme disease by a bacterium—both raise questions about microbial survival, treatment response, and why recovery may vary between patients.

Could Lyme Disease Bacteria Become Dormant?

Some patients ask whether Lyme disease bacteria can remain dormant after treatment. Laboratory studies have identified drug-tolerant populations of Borrelia burgdorferi that survive exposure to certain antibiotics under experimental conditions.

These organisms are often described as persister cells. Unlike genetically resistant bacteria, persister cells may temporarily tolerate antibiotic exposure because they are growing slowly or have entered an altered metabolic state.

Researchers have also investigated round-body forms, biofilm-like aggregates, and other possible survival mechanisms. However, these findings are primarily based on laboratory and animal research.

They do not establish that viable persister organisms remain after recommended treatment or cause persistent symptoms in patients.

Persistent Symptoms Remain Difficult to Explain

Persistent symptoms following Lyme disease may involve multiple factors, including immune dysregulation, inflammation, autonomic dysfunction, coinfections, tissue injury, or persistent infection.

More than one mechanism may be involved, and the explanation may not be the same for every patient.

For a deeper discussion, see persistent Lyme disease mechanisms.

Clinical Implications

The comparison between malaria and Lyme disease does not prove that persistent infection occurs in every patient with ongoing symptoms.

Instead, malaria illustrates a broader scientific principle: successful treatment of the active stage of an infection does not necessarily address every biologic stage of every pathogen.

Whether a comparable process occurs in treated Lyme disease—and whether it contributes to persistent symptoms—remains an important area of investigation.

Clinicians caring for patients with continuing symptoms face difficult questions when patients do not recover as expected following recommended antibiotic treatment.

FAQ

Can Lyme disease bacteria remain dormant?

Laboratory studies have identified drug-tolerant forms of Borrelia burgdorferi. However, whether viable dormant organisms remain after recommended treatment and contribute to persistent symptoms in patients has not been established.

What are persister cells?

Persister cells are a small, drug-tolerant subpopulation of bacteria that can survive antibiotic exposure without necessarily possessing inherited antibiotic resistance. Their clinical importance in treated Lyme disease remains uncertain.

Why compare malaria with Lyme disease?

Malaria provides an established example of a pathogen entering a dormant stage and later reactivating. Researchers compare infections to explore common principles of dormancy, immune evasion, and drug tolerance—not because malaria and Lyme disease behave identically.

Clinical Perspective

Patients frequently ask why some people recover rapidly while others experience prolonged symptoms. The persister theory remains one possible explanation among several mechanisms under investigation.

Laboratory findings should not be dismissed, but they also should not be interpreted as definitive evidence that persister organisms cause persistent symptoms in humans. Additional clinical research is needed to determine whether these findings can be translated into improved diagnostic or treatment strategies.

Clinical Takeaway

Malaria demonstrates that some pathogens can enter dormant stages that require different treatment strategies. Lyme disease persister research raises a related scientific question, but it does not yet establish that drug-tolerant Borrelia burgdorferi causes persistent symptoms following treatment.

Related Article

For additional discussion of combination-therapy research, see Three-Antibiotic Cocktail Clears Persister Lyme Bacteria in Mouse Study.

References

1. Centers for Disease Control and Prevention. Clinical Features of Malaria.
2. Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. Antimicrob Agents Chemother. 2015;59(8):4616-4624.
3. Feng J, Weitner M, Shi W, Zhang S, Sullivan D, Zhang Y. Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library. Antibiotics (Basel). 2015;4(3):397-410.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention